271 related articles for article (PubMed ID: 27026033)
21. Epithelioid Hemangioendothelioma of the Bowel in Crohn's Disease: The First Reported Case.
Spasic S; Brcic I; Freire R; Garcia-Buitrago MT; Rosenberg AE
Int J Surg Pathol; 2019 Jun; 27(4):423-426. PubMed ID: 30238810
[TBL] [Abstract][Full Text] [Related]
22. Cytologic features and immunohistochemical findings of epithelioid hemangioendothelioma (EHE) in effusion: A case series.
Jebastin Thangaiah J; Hanley K; Nomani L; Policarpio-Nicolas ML
Diagn Cytopathol; 2021 Jan; 49(1):E24-E30. PubMed ID: 32797671
[TBL] [Abstract][Full Text] [Related]
23. Poor response to sintilimab plus chemotherapy in a pulmonary epithelioid hemangioendothelioma patient: a case report.
Zeng H; Tang X; Tian X; Liu Y; Tian P
Immunotherapy; 2023 Feb; 15(2):77-83. PubMed ID: 36695105
[TBL] [Abstract][Full Text] [Related]
24. Novel detection of the CAMTA1-WWTR1 fusion gene in extra-adrenal myelolipoma-like lesion: a case report.
Watanabe H; Murakami K; Motoi T; Murakami K; Aoyama Y; Mitomo H; Ishibashi N; Sugawara T; Tabata T; Matsuura T; Sasano H; Nakamura Y
Virchows Arch; 2022 Mar; 480(3):707-712. PubMed ID: 34231054
[TBL] [Abstract][Full Text] [Related]
25. Variant WWTR1 gene fusions in epithelioid hemangioendothelioma-A genetic subset associated with cardiac involvement.
Suurmeijer AJH; Dickson BC; Swanson D; Sung YS; Zhang L; Antonescu CR
Genes Chromosomes Cancer; 2020 Jul; 59(7):389-395. PubMed ID: 32170768
[TBL] [Abstract][Full Text] [Related]
26. [Atypical epithelioid hemangioendothelioma: a clinicopathological analysis of eight cases].
Gong QX; Fan QH; Ding Y; Xiao QX; Wang QY; Tang JL; Song QY; Wang B
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):620-625. PubMed ID: 31422593
[No Abstract] [Full Text] [Related]
27. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant.
Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774
[TBL] [Abstract][Full Text] [Related]
28. Epithelioid hemangioma of bone and soft tissue: a reappraisal of a controversial entity.
Errani C; Zhang L; Panicek DM; Healey JH; Antonescu CR
Clin Orthop Relat Res; 2012 May; 470(5):1498-506. PubMed ID: 21948309
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein.
Tanas MR; Ma S; Jadaan FO; Ng CK; Weigelt B; Reis-Filho JS; Rubin BP
Oncogene; 2016 Feb; 35(7):929-38. PubMed ID: 25961935
[TBL] [Abstract][Full Text] [Related]
30. Epithelioid Hemangioendothelioma Arising Within Mediastinal Myelolipoma: A WWTR1-Driven Composite Neoplasm.
Diaz-Perez JA; Velez-Torres J; Iakymenko O; Villamizar N; Rosenberg AE
Int J Surg Pathol; 2019 Sep; 27(6):664-668. PubMed ID: 30942102
[TBL] [Abstract][Full Text] [Related]
31. CAMTA1 immunostaining is not useful in differentiating epithelioid hemangioendothelioma from its potential mimickers.
Yusıflı Z; Kösemehmetoğlu K
Turk Patoloji Derg; 2014; 30(3):159-65. PubMed ID: 25110239
[TBL] [Abstract][Full Text] [Related]
32. Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma.
Seligson ND; Awasthi A; Millis SZ; Turpin BK; Meyer CF; Grand'Maison A; Liebner DA; Hays JL; Chen JL
JAMA Netw Open; 2019 Oct; 2(10):e1912416. PubMed ID: 31577358
[TBL] [Abstract][Full Text] [Related]
33. Case of epithelioid hemangioendothelioma occurring in the postradiation setting for breast cancer.
Hahn E; Dickson BC; Gupta AA; Nofech-Mozes S
Genes Chromosomes Cancer; 2021 Feb; 60(2):112-115. PubMed ID: 33125182
[TBL] [Abstract][Full Text] [Related]
34. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma.
Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M
Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300
[TBL] [Abstract][Full Text] [Related]
35. YAP1-TFE3 epithelioid hemangioendothelioma: a case without vasoformation and a new transcript variant.
Puls F; Niblett A; Clarke J; Kindblom LG; McCulloch T
Virchows Arch; 2015 Apr; 466(4):473-8. PubMed ID: 25680571
[TBL] [Abstract][Full Text] [Related]
36. TFE3 rearranged epithelioid hemangioendothelioma of bone: A clinicopathological, immunohistochemical and molecular study of two cases.
Zhang HZ; Dong L; Wang SY; Yang XQ
Ann Diagn Pathol; 2020 Jun; 46():151487. PubMed ID: 32151991
[TBL] [Abstract][Full Text] [Related]
37. Loss of CDKN2A Cooperates with WWTR1(TAZ)-CAMTA1 Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma.
Seavey CN; Hallett A; Li S; Che K; Pobbati AV; Ma S; Burtscher A; Kanai R; Lamar JM; Rubin BP
Clin Cancer Res; 2023 Jul; 29(13):2480-2493. PubMed ID: 36598859
[TBL] [Abstract][Full Text] [Related]
38. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
39. What is new in endothelial neoplasia?
Papke DJ; Hornick JL
Virchows Arch; 2020 Jan; 476(1):17-28. PubMed ID: 31463731
[TBL] [Abstract][Full Text] [Related]
40. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.
Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR
Elife; 2021 Apr; 10():. PubMed ID: 33913810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
